Is Theratechnologies Inc. (TSX:TH) the Healthiest High-Growth Pharma Stock on the TSX?

Theratechnologies Inc. (TSX:TH) is a very healthy pharma stock with a huge projected annual growth in earnings. Here’s why else it’s a strong buy.

| More on:
The Motley Fool

Looking for high-growth stock can be a full-time job in itself. Finding stocks that qualify as high-growth, but that also have healthy assets to back it up can be even harder.

One of the best ways to be sure that your high-growth stock will deliver the goods is to take a look at its market share. While most companies have a lot of competitors, every now then you will come across a stock that seemingly has none.

Let’s delve into the factors that might make today’s high-growth stock with a squeaky-clean balance sheet a buy.

Say hello to one of the top pharma stocks on the TSX

Theratechnologies Inc. (TSX:TH) is a specialist pharmaceutical stock in the HIV patient industry. While other stock markets have competitors in this field, Theratechnologies has the monopoly on the TSX index. With solutions for comfortable ageing and quality of life for HIV patients that are largely unmet, Theratechnologies is what you might call a pure-play pharma stock.

It’s also a hungry stock with a canny management strategy. Through its distributors, Theratechnologies has extended its reach across Europe, Israel, Norway, Switzerland, and Russia, as well as making recent inroads in Mexico and Brazil. Offering solutions for drug-resistant HIV sufferers, it’s involved with the development of a novel drug called Ibalizumab. Its main income is from the sales and distribution of its number one product: an abdominal fat reducing drug called EGRIFTA. A market-cornering drug, it has applications beyond HIV patients and can be used to treat forms of diabetes.

Insider investment is a bullish sign in general, and Theratechnologies has seen a rise in insider buying over the last nine months, further adding to the analysis that this stock is worth buying. However, with an overvalued share price of $13.41 compared to its projected future cash flow value of $0.99, value investors may be left scratching their heads.

A cheap stock with a very comfortable future

With under 30 employees and no debt, Theratechnologies qualifies as one of the healthiest high-growth stocks on the TSX. It has a very low level of unsold physical assets, and as such, it looks more than able to deliver on its high growth. Where risk does come into play is its reliance on distributor RxCrossroads, based in the U.S., and its price, which may be overdue for correction. Indeed, the latter may already be happening, as its recent share price spike seems to be declining.

That said, its expected annual growth in earnings is phenomenal. At a massive 105.3%, Theratechnologies could multiply your investment literally a hundredfold. It goes without saying that this beats the expected annual growth of the TSX index by a huge margin, so you can see why analysts are saying that this stock is a strong buy.

The bottom line

Never mind the overvalued share price – this stock is a potential gold mine. Theratechnologies is one of those rare stocks that can seriously multiply your investment. Given that its market is largely untapped — it meets medical needs that no other stock on the TSX is involved with — this stock automatically has the monopoly. All told, it looks like a strong buy from here.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Victoria Hetherington has no position in any of the stocks mentioned.

More on Investing

A data center engineer works on a laptop at a server farm.
Tech Stocks

3 No-Brainer Data Centre Stocks to Buy With $500 Right Now

Data centres are going to be a huge growth opportunity in the next decade. And these are the top buys.

Read more »

Paper Canadian currency of various denominations
Bank Stocks

1 Magnificent Canadian Dividend Stock Down 28% to Buy and Hold for Decades

This top Canadian dividend stock is underperforming its large peers this year, but a turnaround could be on the horizon.

Read more »

TFSA (Tax-Free Savings Account) on wooden blocks and Canadian one hundred dollar bills.
Dividend Stocks

Where to Invest Your $7,000 TFSA Contribution

The TFSA is attractive for investors who want to generate tax-free passive income.

Read more »

The TFSA is a powerful savings vehicle for Canadians who are saving for retirement.
Dividend Stocks

TFSA Investors: 3 Dividend Stocks Worth Holding Forever

These TSX stocks have the potential to grow their dividends over the next decade, making them top investments for TFSA…

Read more »

hand stacks coins
Investing

Secure a Wealthy Future With These 3 Canadian Stocks

These Canadian stocks have the potential to appreciate substantially over time and may also enhance returns through dividend payments.

Read more »

Tractor spraying a field of wheat
Dividend Stocks

Is Nutrien Stock a Buy for its Dividend Yield?

Nutrien is down more than 50% form the 2022 highs. Is NTR stock now oversold?

Read more »

analyze data
Investing

3 Blue-Chip Stocks Every Canadian Should Own

These blue-chip stocks are backed by large-cap companies with well-established businesses, solid fundamentals, and a growing earnings base.

Read more »

dividends grow over time
Stocks for Beginners

The Smartest Growth Stock to Buy With $2,000 Right Now

Do you have $2,000 to invest for the long term? These three TSX stocks have and will continue to deliver…

Read more »